Suzanne Sawochka Hooper has served as a member of Eidos board of directors since August 2020. She brings more than 25 years of executive and corporate leadership experience and sophisticated legal experience to the Eidos board. As executive vice president and general counsel at Jazz Pharmaceuticals from March 2012 through February 2019, Ms. Hooper played an active role in the management and strategic development of the company during a period of substantial growth. Prior to joining Jazz, she was a partner in the Cooley LLP law firm, representing a broad range of companies and investors in the life sciences industry and working with boards of directors and senior management teams on complex legal and strategic matters, including M&A. Ms. Hooper also serves as a member of the Board of Directors of NGM Biopharmaceuticals, Inc. Ms. Hooper received a J.D. from the University of California Berkeley School of Law and a B.A. in Political Science from the University of California, Santa Barbara.